Toronto Dominion Bank’s GSK GSK Stock Holding History

Toronto Dominion Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-39,600	Closed	-$2.07M	–	1576
2019 Q1	$2.07M	Buy	+39,600	New	+$1.98M	﹤0.01%	823

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Toronto Dominion Bank's GSK Position: Q4 2024 in Review

Toronto Dominion Bank sold out of GSK (GSK) in Q4 2024, closing a stake of 80 shares — an estimated $3.27K sold.

Toronto Dominion Bank first reported a position in GSK in Q2 2013 and held it in 36 quarters. The position peaked at $1.07M in Q1 2014. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Toronto Dominion Bank reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Toronto Dominion Bank sold 80 GSK shares in Q4 2024, an estimated $3.27K.
Toronto Dominion Bank first reported a position in GSK in Q2 2013 and held it in 36 quarters.
Toronto Dominion Bank's GSK position peaked at $1.07M in Q1 2014.
849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Toronto Dominion Bank's 13F filing for Q4 2024, filed 14 Feb 2025.